Search

DaVita Inc

Avatud

SektorTervishoid

182.18 -1.8

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

179.69

Max

185.6

Põhinäitajad

By Trading Economics

Sissetulek

68M

343M

Müük

139M

3.6B

P/E

Sektori keskmine

15.543

50.373

Aktsiakasum

4.02

Kasumimarginaal

9.657

Töötajad

78,000

EBITDA

98M

753M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+24.82% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

1. veebr 2027

Turustatistika

By TradingEconomics

Turukapital

-3.2B

12B

Eelmine avamishind

183.98

Eelmine sulgemishind

182.18

DaVita Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. nov 2026, 21:12 UTC

DaVita Inc. is trading modestly lower in after-market hours, continuing a downward trend since Monday's close without significant recovery during the session.

30. okt 2026, 20:02 UTC

News
Social Media

DaVita Inc. is under pressure after Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential claims on behalf of investors.

29. okt 2026, 23:02 UTC

Social Media
News

DaVita reports Q3 earnings of $3.82 per share and $3.58 billion in revenue, but shares fall sharply after disappointing full-year guidance and a $62 million impairment charge.

28. okt 2026, 23:02 UTC

DaVita Inc. is declining in after-market trading, falling significantly below its 20-day moving average and near the lower end of its one-month trading range.

27. okt 2026, 20:07 UTC

News

DaVita Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, following a U.S. Department of Health announcement affecting the dialysis market.

26. okt 2026, 19:36 UTC

DaVita Inc shares are trading modestly higher, remaining above their 20-day moving average and near the upper end of their one-month range.

22. okt 2026, 20:02 UTC

DaVita Inc shares are sharply higher, breaking from a recent trend of higher daily closes and diverging from prior upward momentum.

21. okt 2026, 20:07 UTC

News

DaVita Inc reaffirmed as a "Buy" with a price target of $265 in a report from DBAB, which sees no significant changes to the HHS kidney care plan.

20. okt 2026, 23:06 UTC

DaVita Inc shares traded modestly lower in after-market hours, continuing a downward trend from Tuesday's close and remaining below its 20-day moving average.

16. okt 2026, 19:34 UTC

DaVita Inc shares are declining amid significant market downturns, influenced by stronger-than-expected U.S. industrial production and ongoing inflation concerns.

15. okt 2026, 20:02 UTC

News

DaVita Inc presents seven studies at ASN Kidney Week 2026, showcasing advancements in kidney care and emphasizing its commitment to clinical research.

14. okt 2026, 20:41 UTC

DaVita Inc. saw a modest decline during after-market hours on Wednesday, moving to a loss of nearly one percent as it trades near its one-month range low.

8. okt 2026, 20:07 UTC

DaVita Inc's shares are trading higher, recovering slightly from an earlier low, but remain below their 20-day moving average.

7. okt 2026, 20:08 UTC

DaVita Inc. shares fell sharply amid broader market weakness, retreating from a morning rise and closing down significantly since Tuesday's close.

6. okt 2026, 21:10 UTC

DaVita Inc. has declined sharply in after-market trading, reaching its lowest point of the day and falling below its 20-day moving average.

2. okt 2026, 20:07 UTC

DaVita Inc. shares are higher, having peaked early in the session, and remain above their opening level despite being near the lower end of their one-month range.

1. okt 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting a modest increase since Wednesday's close, despite pulling back from an earlier session high.

28. sept 2026, 20:07 UTC

DaVita Inc's shares fell amid rising crude oil prices and inflation concerns, following a broader market decline that has affected major technology stocks.

25. sept 2026, 20:07 UTC

DaVita Inc. is advancing, reflecting broader market gains, despite earlier pulling back from a session high and remaining below its 20-day moving average.

24. sept 2026, 20:01 UTC

DaVita Inc shares fell, marking a shift in momentum after a streak of higher daily closes in recent sessions.

18. sept 2026, 19:46 UTC

DaVita Inc is modestly higher, recovering from an initial decline, and is currently above its 20-day moving average within its one-month trading range.

17. sept 2026, 22:31 UTC

DaVita Inc is trading higher in after-market hours, reaching a peak above its 20-day moving average and positioned near the midpoint of its one-month range.

16. sept 2026, 20:10 UTC

DaVita Inc has gained ground during Wednesday's trading session, reaching a peak earlier and remaining significantly above its 20-day moving average.

15. sept 2026, 23:56 UTC

DaVita Inc shares are lower in after-market trading amid negative sentiment following a sharp decline in the NY Empire State Manufacturing Index.

14. sept 2026, 23:41 UTC

DaVita Inc. shares declined in after-market trading, reflecting broader market trends amid rising crude oil prices and inflationary concerns.

11. sept 2026, 20:51 UTC

DaVita Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

9. sept 2026, 20:07 UTC

DaVita Inc. is higher in Wednesday trading, recovering from an early decline. The stock remains above its 20-day moving average and near a one-month peak.

8. sept 2026, 20:04 UTC

DaVita Inc is trading lower today amid a decline in the Health Care Services sub-sector and broader market weakness. No specific company news was identified.

3. sept 2026, 20:07 UTC

DaVita Inc shares are higher during Thursday's session, maintaining an upward trend since Wednesday's close amid a broader market rally and declining Treasury yields.

31. aug 2026, 20:02 UTC

DaVita Inc's shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing the decline amid rising interest rate expectations.

Võrdlus sarnastega

Hinnamuutus

DaVita Inc Prognoos

Hinnasiht

By TipRanks

24.82% tõus

12 kuu keskmine prognoos

Keskmine 231.833 USD  24.82%

Kõrge 287 USD

Madal 180 USD

Põhineb 6 Wall Streeti analüütiku instrumendi DaVita Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

3

Osta

2

Hoia

1

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat